Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 160
- −2 vs. Q3 2024
- Portfolio value
- $5.19B
- −$977.4M (−15.8%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEMTempus AI, Inc. | CL A | 237 | $8.00K | <0.1% | −279−54.1% | Reduced | History |
| LHLabcorp Holdings Inc. | Stock | 216 | $49.5K | <0.1% | +10+4.9% | Added | History |
| MTDMettler Toledo International Inc | COM | 42 | $51.4K | <0.1% | +1+2.4% | Added | History |
| QCOMQualcomm Inc | Stock | 447 | $68.7K | <0.1% | +20+4.7% | Added | History |
| MSFTMicrosoft Corp | Stock | 203 | $85.6K | <0.1% | +9+4.6% | Added | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 41,500 | $97.5K | <0.1% | 00.0% | Unchanged | History |
| NVDANVIDIA Corp | Stock | 751 | $100.9K | <0.1% | +35+4.9% | Added | History |
| AAgilent Technologies, Inc. | COM | 806 | $108.3K | <0.1% | +37+4.8% | Added | History |
| ORCLOracle Corp | Stock | 654 | $109.0K | <0.1% | +30+4.8% | Added | History |
| KURAKura Oncology, Inc. | COM | 13,600 | $118.5K | <0.1% | 00.0% | Unchanged | History |
| VCYTVeracyte, Inc. | COM | 3,600 | $142.6K | <0.1% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 8,000 | $150.7K | <0.1% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 8,100 | $160.2K | <0.1% | +8,100 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 4,000 | $168.3K | <0.1% | 00.0% | Unchanged | History |
| BIDUBaidu, Inc. | ADR | 2,000 | $168.6K | <0.1% | 00.0% | Unchanged | History |
| OCSOculis Holding AG | ORDINARY SHARES | 10,000 | $170.0K | <0.1% | +10,000 | New | History |
| PTCTPTC Therapeutics, Inc. | COM | 3,800 | $171.5K | <0.1% | +3,800 | New | History |
| MLYSMineralys Therapeutics, Inc. | COM | 16,499 | $203.1K | <0.1% | 00.0% | Unchanged | History |
| GRMNGarmin Ltd | SHS | 1,050 | $216.6K | <0.1% | 00.0% | Unchanged | History |
| ACLXArcellx, Inc. | COMMON STOCK | 3,000 | $230.1K | <0.1% | −1,000−25.0% | Reduced | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 4,400 | $238.3K | <0.1% | 00.0% | Unchanged | History |
| BPMCBlueprint Medicines Corp | COM | 3,200 | $279.1K | <0.1% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 24,000 | $283.9K | <0.1% | +24,000 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 10,400 | $285.4K | <0.1% | 00.0% | Unchanged | History |
| ADMAAdma Biologics, Inc. | COM | 16,900 | $289.8K | <0.1% | −9,000−34.7% | Reduced | History |
| DNLIDenali Therapeutics Inc. | COM | 15,700 | $320.0K | <0.1% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 8,200 | $321.4K | <0.1% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 8,000 | $336.4K | <0.1% | 00.0% | Unchanged | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 1,100 | $339.4K | <0.1% | 00.0% | Unchanged | History |
| ZLABZai Lab Ltd | ADR | 13,000 | $340.5K | <0.1% | +13,000 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 2,500 | $344.2K | <0.1% | +2,500 | New | History |
| QUREuniQure N.V. | SHS | 22,500 | $397.4K | <0.1% | +22,500 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 23,100 | $402.4K | <0.1% | −7,900−25.5% | Reduced | History |
| BIIBBiogen Inc. | COM | 2,652 | $405.5K | <0.1% | +18+0.7% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 10,941 | $514.7K | <0.1% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 12,939 | $520.7K | <0.1% | −3,240−20.0% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 39,500 | $550.2K | <0.1% | 00.0% | Unchanged | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 25,000 | $642.5K | <0.1% | +17,300+224.7% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 5,047 | $790.7K | <0.1% | +268+5.6% | Added | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 100,414 | $795.3K | <0.1% | +24,000+31.4% | Added | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 26,200 | $888.4K | <0.1% | +26,200 | New | – |
| PTGXProtagonist Therapeutics, Inc | COM | 23,718 | $915.5K | <0.1% | +11,372+92.1% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 8,332 | $949.4K | <0.1% | −389−4.5% | Reduced | History |
| CVSCVS Health Corp | Stock | 21,844 | $980.6K | <0.1% | −222−1.0% | Reduced | History |
| CERTCertara, Inc. | COM | 92,129 | $981.2K | <0.1% | −3,795−4.0% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 12,038 | $985.4K | <0.1% | +57+0.5% | Added | History |
| GOOGAlphabet Inc. | Stock | 6,000 | $1.14M | <0.1% | 00.0% | Unchanged | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 23,596 | $1.32M | <0.1% | +7,896+50.3% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 60,598 | $1.34M | <0.1% | −10,223−14.4% | Reduced | History |
| DOCSDoximity, Inc. | CL A | 27,911 | $1.49M | <0.1% | −1,149−4.0% | Reduced | History |
| RDYDr Reddys Laboratories Ltd | ADR | 97,900 | $1.55M | <0.1% | −5,075−4.9% | ReducedConverted for a 5-for-1 split | History |
| ZTSZoetis Inc. | Stock | 9,779 | $1.59M | <0.1% | +4,495+85.1% | Added | History |
| ACCDAccolade, Inc. | COM | 615,509 | $2.11M | <0.1% | −25,356−4.0% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 38,113 | $2.16M | <0.1% | +1,288+3.5% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 35,700 | $2.34M | <0.1% | +2,200+6.6% | Added | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 377,806 | $2.55M | <0.1% | −15,075−3.8% | Reduced | History |
| CAHCardinal Health Inc | Stock | 22,298 | $2.64M | 0.1% | −7,926−26.2% | Reduced | History |
| BTSGBrightSpring Health Services, Inc. | COM | 174,152 | $2.97M | 0.1% | +174,152 | New | History |
| SMMTSummit Therapeutics Inc. | COM | 170,594 | $3.04M | 0.1% | +106,500+166.2% | Added | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 5,660 | $3.32M | 0.1% | +5,660 | New | History |
| PFEPfizer Inc | Stock | 141,560 | $3.76M | 0.1% | +485+0.3% | Added | History |
| TXG10x Genomics, Inc. | CL A COM | 270,728 | $3.89M | 0.1% | −11,153−4.0% | Reduced | History |
| MASIMasimo Corp | COM | 24,166 | $3.99M | 0.1% | +24,166 | New | History |
| OMCLOmnicell, Inc. | COM | 94,740 | $4.22M | 0.1% | −102,974−52.1% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 48,429 | $4.47M | 0.1% | +2,402+5.2% | Added | History |
| CNCCentene Corp | Stock | 86,456 | $5.24M | 0.1% | −252−0.3% | Reduced | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 167,341 | $5.45M | 0.1% | −1,793−1.1% | Reduced | History |
| WAYWaystar Holding Corp. | COM | 157,898 | $5.79M | 0.1% | +7,696+5.1% | Added | History |
| ILMNIllumina, Inc. | COM | 43,703 | $5.84M | 0.1% | −1,493−3.3% | Reduced | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,061,753 | $5.88M | 0.1% | +19,618+1.9% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 34,229 | $6.32M | 0.1% | −24,500−41.7% | Reduced | History |
| ASTHAstrana Health, Inc. | COM NEW | 205,239 | $6.47M | 0.1% | −48,943−19.3% | Reduced | History |
| ALTAltimmune, Inc. | COM NEW | 945,446 | $6.82M | 0.1% | +81,786+9.5% | Added | History |
| HUMHumana Inc | Stock | 28,367 | $7.20M | 0.1% | −73−0.3% | Reduced | History |
| JNJJohnson & Johnson | Stock | 54,557 | $7.89M | 0.2% | +3,315+6.5% | Added | History |
| FATEFate Therapeutics Inc | COM | 4,839,779 | $7.99M | 0.2% | 00.0% | Unchanged | History |
| ABBVAbbVie Inc. | Stock | 45,259 | $8.04M | 0.2% | +2,373+5.5% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 44,833 | $8.81M | 0.2% | −84,994−65.5% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 60,875 | $9.13M | 0.2% | −2,108−3.3% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 50,327 | $9.29M | 0.2% | −22,788−31.2% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 118,930 | $10.1M | 0.2% | −248,251−67.6% | Reduced | History |
| PHRPhreesia, Inc. | COM | 405,693 | $10.2M | 0.2% | −16,713−4.0% | Reduced | History |
| MCKMcKesson Corp | Stock | 19,315 | $11.0M | 0.2% | −16,427−46.0% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 33,551 | $11.0M | 0.2% | −12,600−27.3% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 192,718 | $12.0M | 0.2% | +22,874+13.5% | Added | History |
| SIBNSI-BONE, Inc. | COM | 880,979 | $12.4M | 0.2% | −563,130−39.0% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 1,113,658 | $12.5M | 0.2% | −1,556,392−58.3% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 485,050 | $13.2M | 0.3% | −144,708−23.0% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 110,230 | $13.9M | 0.3% | +104,605+1,859.6% | Added | History |
| ELVElevance Health, Inc. | Stock | 38,343 | $14.1M | 0.3% | −50,985−57.1% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 1,055,796 | $17.4M | 0.3% | −556,816−34.5% | Reduced | History |
| EHCEncompass Health Corp | COM | 188,522 | $17.4M | 0.3% | +169,289+880.2% | Added | History |
| CORCencora, Inc. | Stock | 77,522 | $17.4M | 0.3% | +5,469+7.6% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 258,483 | $17.8M | 0.3% | −266,951−50.8% | Reduced | History |
| HOLXHologic Inc | COM | 247,886 | $17.9M | 0.3% | +220.0% | Added | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 8,517,839 | $18.2M | 0.4% | 00.0% | Unchanged | History |
| HCAHCA Healthcare, Inc. | COM | 61,883 | $18.6M | 0.4% | −52,642−46.0% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 953,164 | $18.6M | 0.4% | −106,007−10.0% | Reduced | History |
| CSTLCastle Biosciences Inc | COM | 745,982 | $19.9M | 0.4% | −516,048−40.9% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 171,317 | $20.8M | 0.4% | −173,031−50.2% | Reduced | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Moderna Inc60770K907 | CALL | – | $110.0K |
Sold out since Q3 2024 (14)
Positions held at the end of Q3 2024 that are gone from this filing.
| Security | Class | Shares in Q3 2024 | Value in Q3 2024 | % of portfolio in Q3 2024 | History |
|---|---|---|---|---|---|
| OPCHOption Care Health, Inc. | COM NEW | 1,654,878 | $51.8M | 0.8% | History |
| EPIXESSA Pharma Inc. | COM NEW | 7,879,583 | $47.8M | 0.8% | History |
| EXELExelixis, Inc. | COM | 1,600,000 | $41.5M | 0.7% | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 610,000 | $28.7M | 0.5% | History |
| GBIOGeneration Bio Co. | COM | 3,918,856 | $9.68M | 0.2% | History |
| MTEMMolecular Templates, Inc. | COM NEW | 1,279,820 | $1.80M | <0.1% | History |
| SNYSanofi | SPONSORED ADR | 15,109 | $870.7K | <0.1% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 19,046 | $549.3K | <0.1% | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 24,015 | $469.0K | <0.1% | History |
| VTRSViatris Inc | Stock | 39,283 | $456.1K | <0.1% | History |
| NKENIKE, Inc. | Stock | 3,500 | $309.4K | <0.1% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 7,200 | $228.1K | <0.1% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 9,300 | $171.8K | <0.1% | History |
| OABIOmniAb, Inc. | COM | 11,456 | $48.5K | <0.1% | History |